Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Financial Institutions
FISI
$823M
| $151K | ﹤0.01% |
9,584
+740
| +8% | +$12.5K |
|
4902
Pennant Group
PNTG
$1.37B
| $151K | ﹤0.01% |
12,302
-438
| -3% | -$5.57K |
|
4903
Clear Secure
YOU
$4.68B
| $151K | ﹤0.01% |
6,555
+1,751
| +36% | +$43.3K |
|
|
BIG
4904
DELISTED
Big Lots, Inc.
BIG
| $151K | ﹤0.01% |
17,058
-25,612
| -60% | -$217K |
|
4905
Amplify Energy
AMPY
$198M
| $150K | ﹤0.01% |
22,263
-17,979
| -45% | -$125K |
|
4906
Harmonic Inc
HLIT
$1.52B
| $150K | ﹤0.01% |
9,224
+2,359
| +34% | +$37.9K |
|
|
PNT
4907
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $150K | ﹤0.01% |
16,458
+4,554
| +38% | +$40.2K |
|
|
CRON
4908
Cronos Group
CRON
$1.16B
| $149K | ﹤0.01% |
75,411
+6,187
| +9% | +$11.3K |
|
4909
Invesco CurrencyShares Swiss Franc Trust
FXF
$395M
| $149K | ﹤0.01% |
1,504
-10
| -0.7% | -$991 |
|
4910
OraSure Technologies
OSUR
$265M
| $149K | ﹤0.01% |
29,673
+21,012
| +243% | +$126K |
|
4911
Interface
TILE
$2.19B
| $149K | ﹤0.01% |
16,831
+1,516
| +10% | +$11.6K |
|
4912
Universal Technical Institute
UTI
$1.39B
| $149K | ﹤0.01% |
21,575
+7,022
| +48% | +$47.3K |
|
4913
TCW Transform 500 ETF
VOTE
$1.14B
| $149K | ﹤0.01% |
2,903
+603
| +26% | +$29.4K |
|
|
NVRO
4914
DELISTED
NEVRO CORP.
NVRO
| $149K | ﹤0.01% |
5,893
+2,278
| +63% | +$65.8K |
|
4915
Atlanta Braves Holdings Series B
BATRK
$3.44B
| $148K | ﹤0.01% |
3,731
-694
| -16% | -$26.1K |
|
4916
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$148M
| – | – |
0
| – | – |
|
4917
Laureate Education
LAUR
$5.18B
| $148K | ﹤0.01% |
12,257
+2,742
| +29% | +$32.9K |
|
|
TEI
4918
Templeton Emerging Markets Income Fund
TEI
$320M
| $148K | ﹤0.01% |
28,748
-2,500
| -8% | -$12.6K |
|
|
BDN
4919
Brandywine Realty Trust
BDN
$532M
| $147K | ﹤0.01% |
31,588
-9,363
| -23% | -$38.2K |
|
4920
J. Jill
JILL
$283M
| $147K | ﹤0.01% |
6,852
+2,743
| +67% | +$63K |
|
4921
Novavax
NVAX
$1.33B
| $147K | ﹤0.01% |
19,862
+4,932
| +33% | +$38.8K |
|
4922
International Bancshares
IBOC
$4.56B
| $146K | ﹤0.01% |
3,306
+2,684
| +432% | +$117K |
|
4923
BlackRock MuniYield Pennsylvania Quality Fund
MPA
$144M
| $146K | ﹤0.01% |
12,475
| – | – |
|
4924
Republic Bancorp
RBCAA
$1.92B
| $146K | ﹤0.01% |
3,442
+413
| +14% | +$17.2K |
|
4925
Arcturus Therapeutics
ARCT
$234M
| $145K | ﹤0.01% |
5,073
-1,813
| -26% | -$49.4K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.